We interface DNA Nanotechnology and Synthetic Biology for advanced molecular sensing and targeted therapeutics.
Our lab engineers synthetic DNA into functional, stimulus-responsive nanodevices inspired by nature’s regulatory mechanisms. By combining DNA nanotechnology with cell-free systems, we develop programmable networks that detect clinically relevant biomarkers and, in response, produce signaling or therapeutic outputs.
We program synthetic nucleic acids and genes to recognise molecular cues and generate a measurable signal or a therapeutic action.
Prof. Kevin Plaxco from the University of California Santa Barbara came to visit us and to deliver a seminar in our department.
It has been a great pleasure Kevin!
Francesco, Valentina and Viola have presented their projects at the Spring School in Synthetic Biology in Pisa.
Giorgia has given a talk at the “Giornate di Bioanalitica 2026” in Turin organized by the Italian Chemical Society.
Prof. Simona Ranallo receives the “Medaglia Ivano Bertini 2025” during the Avogadro Colloquia.
A selection of articles and interviews covering the work of the NanoSynBio Lab featured in national and international media.
